Pharmaceutical Pellets Market

Global Pharmaceutical Pellets Market Size, Share and Trends Analysis Report, By Technology (Extrusion, Fluid Bed Granulation, Dry Powder Layering, Solution & Suspension Layering, Spray Congealing, and Spray Drying), By Mechanism of Action (Diffusion, Erosion, and Osmosis), Forecast (2022-2028)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2026226 | Category : Pharmaceuticals | Delivery Format: /

The global pharmaceutical pellets market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Pharmaceutical pellets are simple small free-flowing spherical particles. They are formed by agglomeration of fine powder or granules that can be given in the form of tablets and capsules for various conditions. Additionally, pharmaceutical pellets improve the aesthetic appearance of drugs and are compatible with chemically incompatible drugs. The major factor driving the demand for pharmaceutical pellets is the increasing prevalence of chronic diseases across the globe.

According to the Center for Disease Control and Prevention (CDC), 129 million or 51.8% of noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. Additionally, 24.6% (61 million) of adults had 1 chronic condition, and 27.2% (68 million) had equal or more than 2 chronic conditions. Moreover, the market is also growing due to the increasing healthcare infrastructure as well as increased patient acceptance of drugs which has improved due to the innovation of pharmaceutical pellets.

Some major players in the market include Rainbow Health Care Products, Abbott Pharmaceuticals, and Gilead Sciences, Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2021, Gilead Sciences announced that it has received approval for an oral pellet of hepatitis C drug Epclusa from the US FDA for use in young children who cannot swallow tablets. 

Market Coverage

  • The market number available for – 2021-2028
  • Base year- 2021
  • Forecast period- 2022-2028

Segment Covered- 

  • By Technology
  • By Mechanism of Action

Regions Covered-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape- Rainbow Health Care Products, Abbott Pharmaceuticals, and Gilead Sciences, Inc., among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Pharmaceutical Pellets Market Report by Segment

By Technology 

  • Extrusion
  • Fluid Bed Granulation
  • Dry Powder Layering
  • Solution & Suspension Layering
  • Spray Congealing
  • Spray Drying

By Mechanism of Action 

  • Diffusion
  • Erosion
  • Osmosis

Global Pharmaceutical Pellets Market Report by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa